Literature DB >> 2433445

[pGlu6,Pro9]SP6-11, a selective agonist for the substance P P-receptor subtype.

R Laufer, C Gilon, M Chorev, Z Selinger.   

Abstract

Substitution of a single amino acid residue, proline for glycine-9 in [pGlu6]SP6-11, a hexapeptide analogue of substance P, confers on the peptide selective agonist activity toward the SP-P receptor subtype. [pGlu6,Pro9]SP6-11 had 20% and 75% of the activity of [pGlu6]SP6-11 in stimulating, respectively, K+ release from rat parotid slices and contraction of the isolated guinea pig ileum, via the SP-P receptor subtype. In contrast, [pGlu6,Pro9]SP6-11 had substantially reduced activity on SP-E systems such as the hamster urinary bladder and rat duodenum, being about 20-fold less potent than [pGlu6]SP6-11 and 200-670-fold less potent than neurokinin B. In the guinea pig ileum [pGlu6,Pro9]SP6-11 had very low activity on the neuronal tachykinin receptor, being 325 times less potent than [pGlu6]SP6-11 and 1000 times less potent than neurokinin B. Because of its discrimination between the muscular and neuronal receptors in the guinea pig ileum (muscular/neuronal potency ratio = 600), [pGlu6,Pro9]SP6-11 can be used to specifically desensitize the muscular receptor of this tissue. This procedure enables a selective and sensitive bioassay of the neuronal receptor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2433445     DOI: 10.1021/jm00157a029

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  11 in total

1.  Pharmacological properties of a potent and selective nonpeptide substance P antagonist.

Authors:  C Garret; A Carruette; V Fardin; S Moussaoui; J F Peyronel; J C Blanchard; P M Laduron
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

2.  Lack of a role for substance P in the control of dural arterial flow.

Authors:  J Carmody; M Pawlak; K Messlinger
Journal:  Exp Brain Res       Date:  1996-10       Impact factor: 1.972

3.  Evidence that tachykinins relax the guinea-pig trachea via nitric oxide release and by stimulation of a septide-insensitive NK1 receptor.

Authors:  M Figini; C Emanueli; C Bertrand; P Javdan; P Geppetti
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

4.  Contractile activity of the N-acylated C-terminal part of substance P7-11 in guinea pig trachea. Effect of epithelium removal.

Authors:  E Tschirhart; P Schmitt; C Bertrand; M Mayer; S Magneney; Y Landry; R Michelot
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

5.  Subtypes and excitation-contraction coupling mechanisms for neurokinin receptors in smooth muscle of the guinea-pig Taenia caeci.

Authors:  J M Hall; I K Morton
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-08       Impact factor: 3.000

6.  Novel selective agonists and antagonists confirm neurokinin NK1 receptors in guinea-pig vas deferens.

Authors:  J M Hall; I K Morton
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

7.  The two NK-1 binding sites correspond to distinct, independent, and non-interconvertible receptor conformational states as confirmed by plasmon-waveguide resonance spectroscopy.

Authors:  Isabel D Alves; Diane Delaroche; Bernard Mouillac; Zdzislaw Salamon; Gordon Tollin; Victor J Hruby; Solange Lavielle; Sandrine Sagan
Journal:  Biochemistry       Date:  2006-04-25       Impact factor: 3.162

8.  A non-peptide NK1-receptor antagonist, RP 67580, inhibits neurogenic inflammation postsynaptically.

Authors:  S M Moussaoui; F Montier; A Carruette; J C Blanchard; P M Laduron; C Garret
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

9.  Effect of the tachykinin NK1 receptor antagonists, RP 67580 and SR 140333, on electrically-evoked substance P release from rat spinal cord.

Authors:  M Malcangio; N G Bowery
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

10.  Effects of receptor-selective neurokinin agonists and a neurokinin antagonist on the electrical activity of spinal cord neurones in culture.

Authors:  M Wienrich; K Reuss; J Harting
Journal:  Br J Pharmacol       Date:  1989-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.